ECHNO is the European Conference of head and neck oncology planned every year by the European Head and Neck Society that has over 3000 members of professionals of head and neck and beyond in Europe.
This year the conference will be held in a virtual format, with a mutual cooperation between ECHNO and the International Congress of Innovative Approaches in Head and Neck Oncology (ICHNO) and will take place between Wednesday June 30th to Saturday July 3rd 2021.
This congress will present the latest innovating research in the field of head and neck oncology in Europe, it is a great opportunity to meet and network with multidisciplinary contact.
Nanobiotix will present two oral presentations:
July 2, 10.05 am CEST - NBTXR3 activated by SBRT combined with nivolumab or pembrolizumab in patients with advanced cancers: phase I trial by Colette Shen, MD, PhD (Session 5: How to combine immunotherapy with standard of care)
July 2, 11. 45 am CEST - Radiation enhancing hafnium oxide nanoparticles (NBTXR3) for the treatment of locally advanced HNSCC in elderly patients: a phase I/II study by Pr. Christophe Le Tourneau (Session 6: How will we treat our patients non-surgically in 2030?)
The European Society for Medical Oncology (ESMO) Annual Meeting will be virtual this year from 18th to 22nd September. This conference is the opportunity for medical oncologists and other oncology professionals from the many related fields to come together. Pr. Le Tourneau and Pr. De Baere will be there presenting datas.
